ALEXANDER SCOTT

Alzheimer's drug Leqembi has full FDA approval now and that means Medicare will pay for it

​​The Food and Drug Administration endorsed the IV drug, Leqembi, for patients with mild dementia and other symptoms caused by early Alzheimer's disease. It's the first medicine that's been convincingly shown to modestly slow the cognitive decline caused by Alzheimer's.